This site needs JavaScript to work properly. Please enable it to take advantage of the complete set of features!

Skip to main page content

Add to Collections

Your saved search

Name of saved search:

Search terms:

Test search terms

Would you like email updates of new search results?

Yes
No

Email: (change)

Frequency:

Which day?

Which day?

Report format:

Send at most:

Send even when there aren't any new results

Optional text in email:

Your RSS Feed

Review

. 2007 Oct 1;25(28):4329-36.

doi: 10.1200/JCO.2007.12.3968.

Tumor mRNA expression profiles predict responses to chemotherapy

John D Minna, Luc Girard, Yang Xie

PMID: 17906194
DOI: 10.1200/JCO.2007.12.3968

Review

Tumor mRNA expression profiles predict responses to chemotherapy

John D Minna et al. J Clin Oncol. 2007.

. 2007 Oct 1;25(28):4329-36.

doi: 10.1200/JCO.2007.12.3968.

Authors

John D Minna, Luc Girard, Yang Xie

PMID: 17906194
DOI: 10.1200/JCO.2007.12.3968

No abstract available

PubMed Disclaimer

Comment on

Pharmacogenomic strategies provide a rational approach to the treatment of cisplatin-resistant patients with advanced cancer.
Hsu DS, Balakumaran BS, Acharya CR, Vlahovic V, Walters KS, Garman K, Anders C, Riedel RF, Lancaster J, Harpole D, Dressman HK, Nevins JR, Febbo PG, Potti A. Hsu DS, et al. J Clin Oncol. 2007 Oct 1;25(28):4350-7. doi: 10.1200/JCO.2007.11.0593. J Clin Oncol. 2007. Retraction in: J Clin Oncol. 2010 Dec 10;28(35):5229. doi: 10.1200/JCO.2010.33.7311. PMID: 17906199 Retracted.

Similar articles

Integrated pan-cancer gene expression and drug sensitivity analysis reveals SLFN11 mRNA as a solid tumor biomarker predictive of sensitivity to DNA-damaging chemotherapy.
Shee K, Wells JD, Jiang A, Miller TW. Shee K, et al. PLoS One. 2019 Nov 4;14(11):e0224267. doi: 10.1371/journal.pone.0224267. eCollection 2019. PLoS One. 2019. PMID: 31682620 Free PMC article.
Challenges in molecular analysis for individualized cancer therapy.
Clynes M, O'Connor R, O'Driscoll L, Daly C, Meleady P. Clynes M, et al. Drug Discov Today. 2003 Jun 15;8(12):531. doi: 10.1016/s1359-6446(03)02730-2. Drug Discov Today. 2003. PMID: 12821298 No abstract available.
New tools for old drugs: Functional genetic screens to optimize current chemotherapy.
Gerhards NM, Rottenberg S. Gerhards NM, et al. Drug Resist Updat. 2018 Jan;36:30-46. doi: 10.1016/j.drup.2018.01.001. Epub 2018 Jan 12. Drug Resist Updat. 2018. PMID: 29499836 Free PMC article. Review.
Systematic analysis of genotype-specific drug responses in cancer.
Kim N, He N, Kim C, Zhang F, Lu Y, Yu Q, Stemke-Hale K, Greshock J, Wooster R, Yoon S, Mills GB. Kim N, et al. Int J Cancer. 2012 Nov 15;131(10):2456-64. doi: 10.1002/ijc.27529. Epub 2012 Mar 29. Int J Cancer. 2012. PMID: 22422301 Free PMC article.
Identification of molecular determinants of tumor sensitivity and resistance to anticancer drugs.
Quintieri L, Fantin M, Vizler C. Quintieri L, et al. Adv Exp Med Biol. 2007;593:95-104. doi: 10.1007/978-0-387-39978-2_10. Adv Exp Med Biol. 2007. PMID: 17265720 Review.

See all similar articles

Cited by

Are we HER-ting for innovation in neoadjuvant breast cancer trial design?
Snoj N, Bedard PL, de Azambuja E, Cardoso F, Piccart M. Snoj N, et al. Breast Cancer Res. 2009;11(1):201. doi: 10.1186/bcr2209. Epub 2009 Jan 16. Breast Cancer Res. 2009. PMID: 19216727 Free PMC article. Review.
APRIL is a novel clinical chemo-resistance biomarker in colorectal adenocarcinoma identified by gene expression profiling.
Petty RD, Samuel LM, Murray GI, MacDonald G, O'Kelly T, Loudon M, Binnie N, Aly E, McKinlay A, Wang W, Gilbert F, Semple S, Collie-Duguid ES. Petty RD, et al. BMC Cancer. 2009 Dec 11;9:434. doi: 10.1186/1471-2407-9-434. BMC Cancer. 2009. PMID: 20003335 Free PMC article.
Cyclophilin B expression is associated with in vitro radioresistance and clinical outcome after radiotherapy.
Williams PD, Owens CR, Dziegielewski J, Moskaluk CA, Read PW, Larner JM, Story MD, Brock WA, Amundson SA, Lee JK, Theodorescu D. Williams PD, et al. Neoplasia. 2011 Dec;13(12):1122-31. doi: 10.1593/neo.111398. Neoplasia. 2011. PMID: 22241958 Free PMC article.
Survival-related profile, pathways, and transcription factors in ovarian cancer.
Crijns AP, Fehrmann RS, de Jong S, Gerbens F, Meersma GJ, Klip HG, Hollema H, Hofstra RM, te Meerman GJ, de Vries EG, van der Zee AG. Crijns AP, et al. PLoS Med. 2009 Feb 3;6(2):e24. doi: 10.1371/journal.pmed.1000024. PLoS Med. 2009. PMID: 19192944 Free PMC article.
Cancer epigenomics: implications of DNA methylation in personalized cancer therapy.
Toyota M, Suzuki H, Yamashita T, Hirata K, Imai K, Tokino T, Shinomura Y. Toyota M, et al. Cancer Sci. 2009 May;100(5):787-91. doi: 10.1111/j.1349-7006.2009.01095.x. Epub 2009 Feb 19. Cancer Sci. 2009. PMID: 19236379 Free PMC article. Review.

See all "Cited by" articles

Publication types

Actions
Actions
Actions
Actions
Actions

MeSH terms

Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions

Substances

Actions

Grants and funding

LinkOut - more resources

Full Text Sources
- Atypon
- Ovid Technologies, Inc.
Other Literature Sources
- The Lens - Patent Citations Database